Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

In June 2020, Zydus Cadila had received approval from Mexico's
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply